Researchers randomized patients with advanced neuroendocrine tumors 2:1 to receive either cabozantinib or placebo.

M: Metastasis; N: Node; T: Tumor. Data from [21]. Neuroendocrine tumors have demonstrated an increase in incidence and prevalence over the past decades, partly due to increased awareness ...

She had been diagnosed as having metastatic pulmonary neuroendocrine tumor. The patient's medical and family history was unremarkable; she had, however, smoked more than 20 cigarettes per day for ...

18 F-fluorodeoxyglucose positron emission tomography (FDG-PET) is a strong prognosis predictor for neuroendocrine tumors, according to new research from scientists at the Rigshospitalet, ...

Researchers from the Francis Crick Institute have found that some particularly aggressive lung cancer cells can develop their ...

BioIVT’s bank of lung cancer tissue specimens provides access to both ... Cell Carcinoma), Small Cell Lung Cancer and Other Neuroendocrine Lung Tumors, Lung Cancer. Clinical data obtained ...

Exelixis, Inc. (Nasdaq: EXEL) today announced results from a subgroup analysis of the phase 3 CABINET pivotal study of patients with extra-pancreatic ...

Dr. Boris Naraev, a medical oncologist specializing in patient care for those suffering from gastrointestinal, neuroendocrine ...